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Introduction: At synapses, neuronal pentraxin 1 (NPTX1), NPTX2 and NPTX receptor form 
pentamers, playing a role in plasticity by clustering AMPA receptors (O'Brien et al. 2002 
J.Neurosci. 22:4487-98). NPTX1 also mediates amyloidβ-induced neurite degeneration and 
NPTX2 regulates inflammation, a process dysregulated in Alzheimer’s disease (AD) (Abad et al. 
2006 J.Neurosci. 26:12735-47). The liver also secretes pentraxins, e.g. serum amyloid P 
component (SAP) that may enter the brain as the blood-brain-barrier breaks down during AD. 
 
Materials and Methods: Models: Transgenic mice (human APPswe+PSEN1M146V, or TauP301L). 
Human AD brain sections. Hippocampal organotypic slice cultures from wild type mice. 
Patch clamp recording in organotypic slices. 
Immunohistochemistry: antibodies against neuronal pentraxins and SAP; Aβ1-40 and Aβ1-42 
for amyloid pathology; AIF1 and CD68 for microglial number and activation.  
 
Results: We show that NPTX1 and SAP stain amyloid plaques, both in brain sections from AD 
patients and APP+PSEN1 mice, indicating that both pentraxins interact with plaques. 
Interestingly, SAP can form complexes with NPTX family members when they are co-expressed 
in HEK293 cells, suggesting that SAP could interact with neuronal pentraxins. Application of 
nanomolar concentrations of each of the human pentraxins over 7 days reduced paired-pulse 
ratios at CA3-CA1 synapses. This indicates an increase in glutamate release probability, similar 
to that observed in APPswe+PSEN1M146V mice (Cummings et al. 2015 Brain 138:1992-2004). 
Furthermore, our www.mouseac.org database indicates changes in expression of neuronal 
pentraxins at different ages in mouse models (Matarin et al. 2015 Cell Reports 10:633-44). 
 
Finally, we show that NPTX receptor is expressed in BV2 mouse microglial cells and that adding 
NPTX1 or SAP to organotypic hippocampal slices decreases the number of microglia. 
 
Conclusions: Both neuronal and peripheral pentraxins have effects on release of glutamate 
and can interact with AD plaques, possibly modulating the plaque-related microglial response. 
The peripheral pentraxin SAP, when it enters the brain, can form complexes with the neuronal 
pentraxins. 
